A detailed history of Legal & General Group PLC transactions in Vericel Corp stock. As of the latest transaction made, Legal & General Group PLC holds 140,363 shares of VCEL stock, worth $7.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140,363
Previous 140,363 -0.0%
Holding current value
$7.42 Million
Previous $5.93 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.25 - $53.56 $13,731 - $17,407
-325 Reduced 0.23%
140,363 $5.93 Million
Q2 2024

Aug 14, 2024

BUY
$41.71 - $52.9 $273,075 - $346,336
6,547 Added 4.88%
140,688 $6.45 Million
Q1 2024

May 14, 2024

BUY
$32.52 - $52.33 $29,040 - $46,730
893 Added 0.67%
134,141 $6.98 Million
Q4 2023

Feb 15, 2024

SELL
$30.85 - $37.09 $30,726 - $36,941
-996 Reduced 0.74%
133,248 $4.74 Million
Q3 2023

Nov 14, 2023

SELL
$31.69 - $39.25 $3,105 - $3,846
-98 Reduced 0.07%
134,244 $4.5 Million
Q2 2023

Aug 14, 2023

BUY
$29.0 - $38.37 $544,852 - $720,895
18,788 Added 16.26%
134,342 $5.05 Million
Q1 2023

May 15, 2023

BUY
$23.85 - $31.34 $46,173 - $60,674
1,936 Added 1.7%
115,554 $3.39 Million
Q4 2022

Feb 14, 2023

BUY
$17.65 - $27.37 $47,072 - $72,995
2,667 Added 2.4%
113,618 $2.99 Million
Q3 2022

Nov 14, 2022

BUY
$22.62 - $32.54 $16,128 - $23,201
713 Added 0.65%
110,951 $2.57 Million
Q2 2022

Aug 22, 2022

BUY
$22.88 - $39.45 $24,893 - $42,921
1,088 Added 1.0%
110,238 $2.78 Million
Q1 2022

May 16, 2022

SELL
$31.69 - $43.29 $28,267 - $38,614
-892 Reduced 0.81%
109,150 $4.17 Million
Q4 2021

Feb 14, 2022

BUY
$35.2 - $52.6 $152,627 - $228,073
4,336 Added 4.1%
110,042 $4.32 Million
Q3 2021

Nov 15, 2021

BUY
$46.35 - $59.75 $384,287 - $495,387
8,291 Added 8.51%
105,706 $5.16 Million
Q2 2021

Aug 12, 2021

SELL
$47.2 - $67.81 $1.36 Million - $1.96 Million
-28,893 Reduced 22.88%
97,415 $5.11 Million
Q1 2021

May 17, 2021

BUY
$30.93 - $59.48 $3.69 Million - $7.1 Million
119,420 Added 1733.74%
126,308 $7.02 Million
Q4 2020

Feb 12, 2021

SELL
$18.53 - $31.5 $27,665 - $47,029
-1,493 Reduced 17.81%
6,888 $213,000
Q3 2020

Nov 13, 2020

BUY
$14.68 - $19.12 $1,717 - $2,237
117 Added 1.42%
8,381 $155,000
Q2 2020

Aug 14, 2020

BUY
$8.5 - $15.82 $1,419 - $2,641
167 Added 2.06%
8,264 $114,000
Q1 2020

May 14, 2020

SELL
$7.25 - $19.22 $13,825 - $36,652
-1,907 Reduced 19.06%
8,097 $75,000
Q4 2019

Feb 13, 2020

BUY
$13.77 - $19.2 $23,890 - $33,312
1,735 Added 20.98%
10,004 $174,000
Q2 2019

Aug 14, 2019

BUY
$15.01 - $18.89 $7,264 - $9,142
484 Added 6.22%
8,269 $156,000
Q4 2018

Feb 15, 2019

BUY
$10.77 - $18.44 $14,453 - $24,746
1,342 Added 20.83%
7,785 $135,000
Q3 2018

Nov 20, 2018

BUY
$9.1 - $14.8 $8,581 - $13,956
943 Added 17.15%
6,443 $91,000
Q2 2018

Aug 10, 2018

BUY
$9.6 - $14.6 $52,800 - $80,300
5,500 New
5,500 $53,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.5B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.